BR112018005742A2 - composição tópica, método para desinfecção de uma superfície, utilização da composição e utilizações de uma composição - Google Patents

composição tópica, método para desinfecção de uma superfície, utilização da composição e utilizações de uma composição

Info

Publication number
BR112018005742A2
BR112018005742A2 BR112018005742-8A BR112018005742A BR112018005742A2 BR 112018005742 A2 BR112018005742 A2 BR 112018005742A2 BR 112018005742 A BR112018005742 A BR 112018005742A BR 112018005742 A2 BR112018005742 A2 BR 112018005742A2
Authority
BR
Brazil
Prior art keywords
composition
topical
surface disinfection
topical composition
picolinamide
Prior art date
Application number
BR112018005742-8A
Other languages
English (en)
Other versions
BR112018005742B1 (pt
Inventor
Majumdar Amitabha
Swamy Mathapathi Mruthyunjaya
Original Assignee
Unilever Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Nv filed Critical Unilever Nv
Publication of BR112018005742A2 publication Critical patent/BR112018005742A2/pt
Publication of BR112018005742B1 publication Critical patent/BR112018005742B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

a presente invenção se refere a uma composição tópica e mais especialmente a uma composição tópica para o benefício antimicrobiano. de acordo com a presente invenção, é fornecida uma composição tópica que compreende a niacinamida e picolinamida, em que a proporção molar de niacinamida para a picolinamida é a partir de 1:20 a 20:1.
BR112018005742-8A 2015-10-05 2016-10-04 Composição tópica, método não terapêutico para desinfecção de uma superfície e usos não terapêuticos BR112018005742B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15188360.0 2015-10-05
EP15188360 2015-10-05
PCT/EP2016/073626 WO2017060213A1 (en) 2015-10-05 2016-10-04 Composition comprising niacinamide and picolinamide

Publications (2)

Publication Number Publication Date
BR112018005742A2 true BR112018005742A2 (pt) 2018-10-09
BR112018005742B1 BR112018005742B1 (pt) 2021-11-16

Family

ID=54256684

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018005742-8A BR112018005742B1 (pt) 2015-10-05 2016-10-04 Composição tópica, método não terapêutico para desinfecção de uma superfície e usos não terapêuticos

Country Status (13)

Country Link
US (3) US10952952B2 (pt)
EP (2) EP3359124B1 (pt)
JP (2) JP6907196B2 (pt)
KR (1) KR102643373B1 (pt)
CN (2) CN108135824B (pt)
AR (1) AR106261A1 (pt)
BR (1) BR112018005742B1 (pt)
CA (2) CA3000880A1 (pt)
EA (2) EA035440B1 (pt)
MX (2) MX2018004143A (pt)
PH (1) PH12018500619A1 (pt)
WO (2) WO2017060211A1 (pt)
ZA (2) ZA201802005B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3000880A1 (en) 2015-10-05 2017-04-13 Unilever Plc A skin lightening composition
BR112020011640A2 (pt) 2017-12-18 2020-11-17 Unilever Nv composição tópica, método de desinfecção de superfícies e usos da composição
CA3146376A1 (en) * 2019-07-12 2021-01-21 Unilever Global Ip Limited Bioenergetic combinations and methods of using same
WO2021249760A1 (en) * 2020-06-10 2021-12-16 Unilever Ip Holdings B.V. A cosmetic composition comprising 6-methyl-picolinamide
US11696889B2 (en) 2020-08-07 2023-07-11 David Levy Botanical antimicrobial composition
WO2023175061A1 (en) * 2022-03-18 2023-09-21 Unilever Ip Holdings B.V. A skin brightening composition

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1370236A (en) * 1972-01-11 1974-10-16 Unilever Ltd Skin composition
GB1533119A (en) * 1975-04-10 1978-11-22 Unilever Ltd Skin lightening compositions
GB8910366D0 (en) * 1989-05-05 1989-06-21 Unilever Plc Skin composition
TW233264B (pt) 1992-02-03 1994-11-01 Otsuka Pharma Co Ltd
US5411741A (en) * 1993-07-29 1995-05-02 Zaias; Nardo Method and composition for skin depigmentation
JP2002506821A (ja) 1998-03-16 2002-03-05 ザ、プロクター、エンド、ギャンブル、カンパニー 皮膚刺激の治療方法
US20010036924A1 (en) 2000-03-21 2001-11-01 Weidner Morten Sloth Chemical complex comprising a substituted pyridine carboxy derivative and a glucosaminoglycan
US20030105034A1 (en) 2001-07-05 2003-06-05 Astion Deveopment A/S Pyridine carboxy derivatives and an aminosugar
FR2827763B1 (fr) 2001-07-24 2005-09-23 Cs Substance alkyloside inhibant la fixation de microorganismes, utilisation topique et composition contenant au moins une telle substance
JP3908969B2 (ja) * 2002-03-18 2007-04-25 ピアス株式会社 化粧料
ES2274236T3 (es) 2002-06-20 2007-05-16 Astion Dermatology A/S Complejos novedosos de esteres de acidos grasos de polihidroxialcanos y nacinamida.
JP2004123554A (ja) 2002-09-30 2004-04-22 Pias Arise Kk 皮膚バリア機能改善物質、皮膚のしわ改善物質、および該物質を含む皮膚外用剤、化粧料および医薬部外品
US20090105188A1 (en) * 2007-10-17 2009-04-23 Nationwide Children's Hospital, Inc. Compositions and Methods for Treating Necrotizing Enterocolitis
US20090317341A1 (en) 2008-06-18 2009-12-24 Conopco, Inc., D/B/A Unilever Compositions for Lightening Skin Color
EP2313074A4 (en) 2008-06-30 2015-04-15 Elc Man Llc TOPICAL COMPOSITIONS CONTAINING ISONICOTINAMIDE
EP3330252B1 (en) * 2008-11-11 2020-02-12 Signum Biosciences, Inc. Isoprenyl compounds and methods thereof
WO2011133692A1 (en) * 2010-04-20 2011-10-27 Cedars-Sinai Medical Center Boosting immune defense by upregulating ccaat/enhancer binding protein epsilon
EP2522331A1 (en) 2011-05-09 2012-11-14 DSM IP Assets B.V. Use of resveratrol and niacinamide
WO2013030794A2 (en) * 2011-08-31 2013-03-07 Behrooz Kasraee Use of substituted pyridines as skin depigmenting compounds
US20140161750A1 (en) * 2012-12-12 2014-06-12 Thomas Christopher Balshi Sunscreen composition with pigment correcting properties
EP3120850B1 (en) * 2012-12-14 2018-11-07 Unilever N.V. Niacinamide for inducing generation of antimicrobial peptides
US9597271B2 (en) 2013-10-24 2017-03-21 The Procter & Gamble Company Cosmetic compositions and methods
CN106413680A (zh) 2014-05-12 2017-02-15 荷兰联合利华有限公司 用于诱导抗微生物肽生成的烟酰胺
CA3000880A1 (en) * 2015-10-05 2017-04-13 Unilever Plc A skin lightening composition

Also Published As

Publication number Publication date
US11298312B2 (en) 2022-04-12
JP6907196B2 (ja) 2021-07-21
CA3000880A1 (en) 2017-04-13
EP3359124A1 (en) 2018-08-15
KR102643373B1 (ko) 2024-03-07
JP2018529741A (ja) 2018-10-11
MX2018004143A (es) 2018-06-13
JP6880011B2 (ja) 2021-06-02
CN108135824A (zh) 2018-06-08
MX2018004144A (es) 2018-06-13
CA3000296A1 (en) 2017-04-13
US20180280278A1 (en) 2018-10-04
PH12018500619B1 (en) 2018-10-01
ZA201802005B (en) 2019-07-31
EA201890889A1 (ru) 2018-09-28
WO2017060211A1 (en) 2017-04-13
EP3359124B1 (en) 2020-06-03
MX365369B (es) 2019-05-31
US10660840B2 (en) 2020-05-26
EP3359261B1 (en) 2019-05-15
EP3359261A1 (en) 2018-08-15
EA201890886A1 (ru) 2018-09-28
BR112018005742B1 (pt) 2021-11-16
JP2018529735A (ja) 2018-10-11
AR106261A1 (es) 2017-12-27
CN108136232A (zh) 2018-06-08
EA035789B1 (ru) 2020-08-11
PH12018500619A1 (en) 2018-10-01
US20180296457A1 (en) 2018-10-18
EA035440B1 (ru) 2020-06-15
ZA201802233B (en) 2019-07-31
CN108136232B (zh) 2021-08-13
WO2017060213A1 (en) 2017-04-13
US20200230045A1 (en) 2020-07-23
US10952952B2 (en) 2021-03-23
KR20180054647A (ko) 2018-05-24
CN108135824B (zh) 2021-09-17

Similar Documents

Publication Publication Date Title
BR112018005742A2 (pt) composição tópica, método para desinfecção de uma superfície, utilização da composição e utilizações de uma composição
BR112018004620A2 (pt) moduladores da expressão de kras
BR112016028476A2 (pt) compostos, composição, utilização de um composto, método para o combate dos fungos nocivos e sementes
BR112016007065A2 (pt) composto, composição, utilização de um composto e método para o controle da vegetação
BR112018007395A2 (pt) 2,4-di-hidróxi-nicotinamidas como agonistas de apj
BR112015024674A2 (pt) método para aumentar a capacidade de sobrevivência de um ou mais microrganismos benéficos e para revestir uma semente, e, composição
CL2016000839A1 (es) Composiciones para modular la expresión de c9orf72.
BR112017003658A2 (pt) composto, mistura, métodos para tratamento de uma doença e para inibição de uma glicosidase, e, composição farmacêutica.
BR112016006527A2 (pt) composto, composição, utilização de um composto e método para o controle da vegetação
BR112018000482A2 (pt) ?composição herbicida, utilização da composição, método para o controle da vegetação indesejada e utilização?
CL2014002077A1 (es) Composicion farmaceutica que comprende fumarato de dimetilo; metodo de preparacion; capsula que comprende microtabletas de fumarato de dimetilo; metodo para el tratamiento, profilaxis o mejora de la esclerosis multiple.
BR112014021104A2 (pt) métodos e composições para o tratamento da doença de huntington
CO2017013065A2 (es) Moduladores de diaciglicerol aciltransferasa 2 (dgat2)
BR112018010873A2 (pt) compostos e métodos para inibir a produção de trimetilamina
BR112016022593A2 (pt) composições e métodos para modular a expressão do fator b do complemento
BR112012023910A2 (pt) preparações cosméticas ou dermatológicas com um teor de um ou mais derivados de tiazol
BR112018003864A2 (pt) método para preparação de uma composição de ácido hialurônico, composição, e, método para restauração de um tecido
BR112018010140A2 (pt) compostos de fórmula, composição, utilização de um composto de fórmula, método para o combate de fungos fitopatogênicos e semente
BR112012020078A2 (pt) composição de tratamento de roupa método de tratamento de um produto têxtil de roupa
BR112018010316A2 (pt) compostos de fórmula, composição, utilização de um composto de fórmula, método para o combate de fungos fitopatogênicos e semente
BR112018069741A2 (pt) composição para aplicação tópica, e, método para fabricar uma composição para aplicação tópica.
EA201890186A1 (ru) Применение штаммов микробактерий для получения антибактериальных агентов
CR20150417A (es) Compuestos de azetidiniloxifenilpirrolidina
BR112015016194A2 (pt) compostos, composição, utilização de um composto, método para o combate dos fungos nocivos e semente revestida
BR112018069900A2 (pt) composição antimicrobiana, método de limpeza ou desinfecção de uma superfície e uso de um complexo fosfolipídico catiônico

Legal Events

Date Code Title Description
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B25A Requested transfer of rights approved

Owner name: UNILEVER IP HOLDINGS B.V. (PB)

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 04/10/2016, OBSERVADAS AS CONDICOES LEGAIS.